
Sarepta Therapeutics Inc (NASDAQ:SRPT): Acceptance Brings Profits
Boston, MA 04/21/2014 (wallstreetpr) – Sarepta Therapeutics Inc (NASDAQ:SRPT) has experienced a drastic upheaval after the announcement that the U.S. Food and Drug Administration has accepted













